Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
- 1 February 2009
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 60 (1), 307-320
- https://doi.org/10.1146/annurev.med.60.053107.103955
Abstract
The presence and consequences of resistance to drugs used for the treatment of tuberculosis have long been neglected. The recent detection and recognition of widespread multiple-drug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have raised interest and concern among clinicians and public health authorities globally. In this article, we describe the current global status of drug-resistant tuberculosis. We discuss the development of resistance, current management, and strategies for control.Keywords
This publication has 50 references indexed in Scilit:
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2008
- Randomized Trials to Optimize Treatment of Multidrug-Resistant TuberculosisPLoS Medicine, 2007
- Treatment Options for HIV‐Associated TuberculosisThe Journal of Infectious Diseases, 2007
- Implementation Issues in Tuberculosis/HIV Program Collaboration and Integration: 3 Case StudiesThe Journal of Infectious Diseases, 2007
- Managing multiple and extensively drug-resistant tuberculosis and HIVExpert Opinion on Pharmacotherapy, 2007
- Natural Ventilation for the Prevention of Airborne ContagionPLoS Medicine, 2007
- XDR-TB in South Africa: No Time for Denial or ComplacencyPLoS Medicine, 2007
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006
- Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis controlAIDS, 2006
- Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosisCurrent Opinion in Pulmonary Medicine, 2006